AADI Enlists NY Court To Enforce Cancer Drug Award

By Caroline Simson · December 11, 2024, 9:06 PM EST

California-based AADI Bioscience Inc. is asking a New York federal court to enforce an arbitral award rejecting a more than $15 million claim asserted by a Hong Kong biopharmaceutical company following...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Brief
Award

Case Information

Case Title

Aadi Bioscience, Inc. v. EOC Pharma (Hong Kong) Limited

Case Number

Court

New York Southern

Nature of Suit

Other Statutes: Arbitration

Date Filed

December 10, 2024

Recent Articles By Caroline

November 15, 2024
Ariz. Judge Will Decide Proper Venue For CVS Antitrust Suit
October 25, 2024
DC Circ. Could Nix OK Of $8M Equatorial Guinea Award
October 24, 2024
2nd Circ. Says Healthcare Arbitrations Were Properly Halted
October 09, 2024
$140M Chilean Hospital Award Fight Is Paused In Canada
September 30, 2024
Webuild Escapes Suit Over $140M Award In Delaware
July 10, 2024
Meijer Says Takeda Can't Force Antitrust Suit Into Arbitration
July 05, 2024
UpHealth Says $110M Glocal Award Can Be Enforced
May 20, 2024
Justices Turn Away Hospital Construction Feud
May 15, 2024
High Court Urged To Take Up Hospital Construction Feud
May 03, 2024
BVI Co. Looks To Force $195M PPE Fight Into Arbitration